The last time fatality from the disease was recorded on Apr 13
Pfizer could seek broad clearance for COVID-19 vaccine boosters this week: Washington Post
Pfizer and German partner BioNTech are expected to seek authorisation for their COVID-19 vaccine booster shot for people aged 18 and above as soon as this week, Washington Post reported on Monday, citing officials familiar with the situation.
Published : 8 Nov 2021, 04:08 PM
Updated : 8 Nov 2021, 04:08 PM
The US Food and Drug Administration, FDA, in September authorised the extra shot for those aged 65 and above, people at high risk of severe disease, and others regularly exposed to the virus.
Pfizer and US health officials have argued that the boosters prevent hospitalisations and deaths and that emerging data indicates they can slow mild infections as well.
Pfizer did not immediately respond to requests for comment.
RELATED STORIES
DRAP sent suspect drums of propylene glycol, a sweet-tasting alcohol used in over-the-counter medicines such as cough syrups, for testing
Chinese scientists last year suggested raccoon dogs may also have been involved in coronavirus reaching humans
The last time fatality from the disease was recorded on Mar 23
